Lancashire and South Cumbria
Formulary
Formulary
2 Cardiovascular system
02-05-01 Vasodilator antihypertensive drugs
| Hydralazine |
|
Formulary
|
Tablets 25mg, 50mg Heart failure Initiated in hospital or under specialist supervision. |
 NG106: Chronic heart failure in adults: diagnosis and management |
|
| Sildenafil |
|
Formulary
|
Tablets 20mg Tertiary centre only. |
|
MHRA Drug Safety Update Nov 18: Sildenafil (Revatio and Viagra): reports of persistent pulmonary hypertension of the newborn (PPHN) following in-utero exposure in a clinical trial on intrauterine growth restriction |
|
unlicensedLinks
Enoxaparin Shared Care Guideline **FOR USE IN THE MORECAMBE BAY REGION ONLY**- Low Molecular Weight Heparins - Use in Primary care Best Practice Guideline *FOR USE IN PENNINE REGION ONLY*
- LSCMMG: Atrial Fibrillation
- LSCMMG: Heart Failure - Primary Care Guideline for the Use of SGLT-2 Inhibitors in Reduced Ejection Fraction Heart Failure
- LSCMMG: Lipid Management Pathway for Primary Prevention of Cardiovascular Disease
- LSCMMG: Lipid Management Pathway for Secondary Prevention of Cardiovascular Disease
- LSCMMG: Low Molecular Weight Heparins (LMWHs) Summary Prescribing Guide
- MHRA Drug Safety Update August 2016: Riociguat (Adempas): not for use in patients with pulmonary hypertension associated with idiopathic interstitial pneumonias
- MHRA Drug Safety Update Nov 18: Sildenafil (Revatio and Viagra): reports of persistent pulmonary hypertension of the newborn (PPHN) following in-utero exposure in a clinical trial on intrauterine growth restriction
- MHRA: Clopidogrel and proton pump inhibitors: interaction—updated advice
- National Pulmonary Hypertension commissioning policy
- National Pulmonary Hypertension commissioning policy
- NG 185 - Acute coronary syndromes
- NG 196 - Atrial fibrillation: diagnosis and management
- NG106: Chronic heart failure in adults: diagnosis and management
- NICE NG106: Chronic heart failure in adults: diagnosis and management
- NICE NG136: Hypertension in adults: diagnosis and management
- NICE NG167: COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders
- NICE NG187: Acute heart failure: diagnosis and management
- NICE NG203: Chronic kidney disease: assessment and management
- NICE NG95: Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis
- NICE TA731:Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal)
- NICE: review of evidence